Laura Martin, Needham senior internet and media analyst, joins 'The Exchange' to discuss Apple ahead of the stock's earnings ...

Fintel reports that on August 1, 2025, Needham initiated coverage of Turning Point Brands (NYSE:TPB) with a Hold ...

A 76-year-old man has been remanded in custody after allegedly lacing sweets with sedatives at a children’s summer camp in ...

Reddit, Inc. (NYSE:RDDT) is one of the best multibagger stocks according to hedge funds. On July 23, 2025, Needham analyst ...

Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

Shares of Coinbase Global Inc. fell after the largest US crypto exchange reported lower-than-estimated second-quarter revenue ...

KLA Corporation (KLAC) separated itself from rivals such as ASML (ASML) and TE Connectivity (TEL) in its fourth quarter ...

Even head coach Kevin Stefanski couldn't hold back his frustrations over what he called a 'sloppy' day of practice on Day 8 of training camp. His silver lining, ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best biotech penny stocks to buy right now. On July 1, analyst Gil Blum from Needham maintained a Buy rating on Taysha Gene Therapies, Inc.